Literature DB >> 19277691

Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology.

Ilse C Niemeijer1, Marinus C G van Praag, Nicolette van Gemund.   

Abstract

BACKGROUND: Erythema multiforme (EM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) can be distinguished by location, morphology and extent of cutaneous and mucosal lesions. EM has minimal effects on pregnancy and the genital tract. SJS and TEN on the other hand are related with premature labor and vaginal scarring that can lead to long-term painful lesions, stenosis, vaginal adenosis and telangiectasia. CASE: A 33-year-old G3P2 with a medical history of SJS has multiple recurrences during pregnancy of what seems to be EM instead of SJS with a favorable outcome.
CONCLUSION: Differentiation between EM, SJS and TEN is important in gynecology to predict the effects of the diseases on the genital tract and on pregnancy.

Entities:  

Mesh:

Year:  2009        PMID: 19277691     DOI: 10.1007/s00404-009-1008-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

1.  Prevention of vulvovaginal sequelae in stevens-johnson syndrome and toxic epidermal necrolysis.

Authors:  Daniel J Kaser; David E Reichman; Marc R Laufer
Journal:  Rev Obstet Gynecol       Date:  2011

2.  Study of genital manifestations of Stevens Johnson Syndrome/Toxic Epidermal Necrolysis.

Authors:  Anirudha Gulanikar; Arundha Abrol; Saujanya Sagar
Journal:  Indian J Sex Transm Dis AIDS       Date:  2022-06-07

Review 3.  Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review.

Authors:  Ajay N Sharma; Bobak Hedayati; Natasha A Mesinkovska; Scott Worswick
Journal:  Int J Womens Dermatol       Date:  2020-04-13

4.  SJS/TEN 2019: From science to translation.

Authors:  Wan-Chun Chang; Riichiro Abe; Paul Anderson; Wanpen Anderson; Michael R Ardern-Jones; Thomas M Beachkofsky; Teresa Bellón; Agnieszka K Biala; Charles Bouchard; Gianpiero L Cavalleri; Nicole Chapman; James Chodosh; Hyon K Choi; Ricardo R Cibotti; Sherrie J Divito; Karen Dewar; Ulrike Dehaeck; Mahyar Etminan; Diane Forbes; Esther Fuchs; Jennifer L Goldman; James H Holmes; Elyse A Hope; Shuen-Iu Hung; Chia-Ling Hsieh; Alfonso Iovieno; Julienne Jagdeo; Mee Kum Kim; David M Koelle; Mario E Lacouture; Sophie Le Pallec; Rannakoe J Lehloenya; Robyn Lim; Angie Lowe; Jean McCawley; Julie McCawley; Robert G Micheletti; Maja Mockenhaupt; Katie Niemeyer; Michael A Norcross; Douglas Oboh; Cristina Olteanu; Helena B Pasieka; Jonathan Peter; Munir Pirmohamed; Michael Rieder; Hajirah N Saeed; Neil H Shear; Christine Shieh; Sabine Straus; Chonlaphat Sukasem; Cynthia Sung; Jason A Trubiano; Sheng-Ying Tsou; Mayumi Ueta; Simona Volpi; Chen Wan; Hongsheng Wang; Zhao-Qing Wang; Jessica Weintraub; Cindy Whale; Lisa M Wheatley; Sonia Whyte-Croasdaile; Kristina B Williams; Galen Wright; Sonia N Yeung; Li Zhou; Wen-Hung Chung; Elizabeth J Phillips; Bruce C Carleton
Journal:  J Dermatol Sci       Date:  2020-03-07       Impact factor: 4.563

5.  Vaginal Reconstruction for Vaginal Obliteration Secondary to Stevens Johnson Syndrome: A Case Report and Review of Literature.

Authors:  Gokhan Boyraz; Derman Basaran; M Coskun Salman; Nejat Ozgul; Kunter Yuce
Journal:  Oman Med J       Date:  2017-09

6.  Clinicopathologic features and outcomes of primary vaginal adenosis as a dermatologic and gynecologic burden: A retrospective study.

Authors:  Tiantian Han; Ying Jin; Yan Li; Yalan Bi; Lingya Pan
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  Stevens-Johnson syndrome with vulvar involvement: A case report and literature review.

Authors:  Jessie Hollingsworth; Selena U Park; Veena Bhagavathi; Ashlee Green; Nancy Philips
Journal:  Case Rep Womens Health       Date:  2022-03-14

8.  Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected Women.

Authors:  Lauren Knight; Gail Todd; Rudzani Muloiwa; Mushi Matjila; Rannakoe J Lehloenya
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.